Vetoquinol Names Dr. Eric M. Alsup as Country Manager, USA
Published: Apr 03, 2013
FORT WORTH, Texas, April 3, 2013 /PRNewswire/ -- Vetoquinol USA announces the appointment of Dr. Eric M. Alsup as country manager for Vetoquinol USA. Alsup will replace Daniel Beauchamp, who is leaving Vetoquinol to pursue a new opportunity.
Alsup's 20-year career in animal health includes a number of U.S. and international management positions at Elanco Animal Health, including country director for Elanco Italy and head of global marketing for cattle. He left Elanco Animal Health to become vice president for cattle at Intervet, and continued as business unit head for cattle through the acquisitions by Schering-Plough and Merck. Alsup joined Vetoquinol in January of this year in a business development role for the Americas.
"Eric is a proven leader who has helped to grow some of the most highly regarded animal health companies in the world," said Tom Robitaille, group director of Vetoquinol Americas and head of the company's operations in the United States, Canada, Mexico and Brazil. "His experience in the veterinary community is a perfect fit for our organization, while his background in global marketing and sales initiatives adds to our already thriving United States team."
Alsup holds a Master of Business Administration from the Kellogg School of Management at Northwestern University and a Doctor of Veterinary Medicine from Kansas State University. He assumes the responsibilities of country manager on the departure of Mr. Beauchamp, who has made a tremendous contribution to Vetoquinol in his roles as country manager in the U.S. and previously as country manager in Canada.
About Vetoquinol USA
Headquartered in Fort Worth, Texas, Vetoquinol USAmakers of Vetoquinol-branded products and the former Vet Solutions® product portfoliois owned by Vetoquinol SA, a family-owned, independent French pharmaceutical company founded in 1933. Dedicated exclusively to animal health, Vetoquinol USA is focused on the development, production and marketing of FDA, EPA and AAFCO-regulated pharmaceutical, nutritional and dermatological products for dogs and cats. Vetoquinol USA's VET Business Unit specializes in anti-infective, pain management and cardio/nephrology products such as Surolan®, Vetprofen® and Azodyl®, and industry-leading nutritionals such as Laxatone® and Nutri-Cal®. The company's dermatological offerings include Vet Solutions® and Micro Pearls® Advantage shampoos and grooming products. For more information about Vetoquinol USA's products, visit www.vetoquinolusa.com.